GSK enters into patent settlement agreement with Genentech and City of Hope
GSK is Genmab’s development and commercial collaborator for the CD20 antibody of atumumab. The dispute concerned two US patents issued to Genentech and City of Hope, which are
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.